mmm, no, the point was..
a strain of H1N1 which is resistant to the most commonly used anti-viral has now arisen. This will reduce the ability to treat those who have become infected.
and
in the trial of a new vaccine, 95% of those given the treatment produced the nessesary antibodies to make them immune to the virus. The 5% did not and do not carry the immunity. This will allow for the protection of people like, those who are already compromised, healthcare and essential services workers (whose absence from work would worsen any major outbreak), etc.
